Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in China / NCT04010201
Recruiting Observational

A Registered Cohort Study on Brain Calcification

NCT04010201 · tracked via the Priya Life Science China tracker
Sponsor
Wan-Jin Chen
Phase
Observational
Started
2019-08-25
Last updated
2019-09-23

Condition(s) studied

Brain Calcification

Study summary

Brain calcification is a common neuroimaging feature in patients with metabolic, neurological, or developmental disorders, infectious diseases, traumatic or toxic history, as well as in otherwise normal older people. To understand the clinical and genetic characteristics of brain calcification, we establish a cohort of brain calcification to follow up patients with brain calcification.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Patients with brain calcium deposit(s) based on examinations of CT scans * Patients with total calcification score(TCS) greater than the physiological threshold * Relatives of brain calcification patients. * Unrelated healthy controls * Participants or Parent(s)/legal guardian(s) willing and able to complete the informed consent process Exclusion Criteria: * Brain calcification caused by specific secondary factors such as infection, poisoning, and trauma * Participants declining or unable to comply with trial procedures and visit schedule

Primary outcome measure(s)

  • The incidence of hereditary brain calcification — Up to 20 years
    Look for the causative gene in the patient with brian calcification

Trial sites (1)

FacilityCityRegionStatus
Department of Neurology, First Affiliated Hospital Fujian Medical University Fuzhou Fujian Recruiting

More Wan-Jin Chen trials in China

A Registered Cohort Study on Spastic Paraplegia Recruiting
A Registered Cohort Study on Wilson's Disease Recruiting
Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke Active, not recruiting
A Registered Cohort Study on SMA Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04010201 on ClinicalTrials.gov ↗ ← All trials in China